Exascale Labs Holdings Inc. (NASDAQ: XLAB) Stock Competitors & Peer Comparison
See XLAB's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Information Technology Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for XLAB and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| XLAB | $4.66 | +15.35% | 100.6M | 23.15 | $0.20 | N/A |
| IBM | $234.67 | +1.28% | 221.1B | 19.76 | $11.88 | +2.89% |
| ACN | $187.45 | -0.12% | 118.2B | 14.10 | $13.70 | +3.36% |
| INFY | $11.75 | -1.88% | 49.1B | 14.59 | $0.83 | +4.33% |
| FI | $63.80 | +0.16% | 34.3B | 9.86 | $6.47 | N/A |
| CTSH | $62.63 | -1.21% | 29.1B | 11.73 | $5.51 | +2.01% |
| FISV | $53.26 | +2.46% | 28.1B | 8.15 | $6.47 | N/A |
| FIS | $41.86 | -0.02% | 21.9B | 7.01 | $6.03 | +4.00% |
| BR | $173.98 | -2.29% | 20.7B | 18.57 | $9.64 | +2.25% |
| CDW | $153.84 | +3.48% | 19.7B | 14.70 | $10.47 | +1.65% |
Stock Comparison
International Business Machines Corporation (NYSE: IBM)
XLAB vs IBM Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, IBM has a market cap of 221.1B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while IBM trades at $234.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas IBM's P/E ratio is 19.76. In terms of profitability, XLAB's ROE is N/A, compared to IBM's ROE of +0.34%. Regarding short-term risk, XLAB is more volatile compared to IBM. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check IBM's competition here
Accenture plc (NYSE: ACN)
XLAB vs ACN Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, ACN has a market cap of 118.2B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while ACN trades at $187.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas ACN's P/E ratio is 14.10. In terms of profitability, XLAB's ROE is N/A, compared to ACN's ROE of +0.25%. Regarding short-term risk, XLAB is more volatile compared to ACN. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check ACN's competition here
Infosys Limited (NYSE: INFY)
XLAB vs INFY Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, INFY has a market cap of 49.1B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while INFY trades at $11.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas INFY's P/E ratio is 14.59. In terms of profitability, XLAB's ROE is N/A, compared to INFY's ROE of +0.33%. Regarding short-term risk, XLAB is more volatile compared to INFY. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check INFY's competition here
Fiserv, Inc. (NYSE: FI)
XLAB vs FI Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, FI has a market cap of 34.3B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while FI trades at $63.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas FI's P/E ratio is 9.86. In terms of profitability, XLAB's ROE is N/A, compared to FI's ROE of +0.11%. Regarding short-term risk, XLAB is more volatile compared to FI. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check FI's competition here
Cognizant Technology Solutions Corporation (NASDAQ: CTSH)
XLAB vs CTSH Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, CTSH has a market cap of 29.1B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while CTSH trades at $62.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas CTSH's P/E ratio is 11.73. In terms of profitability, XLAB's ROE is N/A, compared to CTSH's ROE of +0.15%. Regarding short-term risk, XLAB is more volatile compared to CTSH. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CTSH's competition here
Fiserv, Inc. (NASDAQ: FISV)
XLAB vs FISV Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, FISV has a market cap of 28.1B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while FISV trades at $53.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas FISV's P/E ratio is 8.15. In terms of profitability, XLAB's ROE is N/A, compared to FISV's ROE of +0.11%. Regarding short-term risk, XLAB is more volatile compared to FISV. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check FISV's competition here
Fidelity National Information Services, Inc. (NYSE: FIS)
XLAB vs FIS Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, FIS has a market cap of 21.9B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while FIS trades at $41.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas FIS's P/E ratio is 7.01. In terms of profitability, XLAB's ROE is N/A, compared to FIS's ROE of +0.23%. Regarding short-term risk, XLAB is more volatile compared to FIS. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check FIS's competition here
Broadridge Financial Solutions, Inc. (NYSE: BR)
XLAB vs BR Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, BR has a market cap of 20.7B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while BR trades at $173.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas BR's P/E ratio is 18.57. In terms of profitability, XLAB's ROE is N/A, compared to BR's ROE of +0.40%. Regarding short-term risk, XLAB is more volatile compared to BR. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check BR's competition here
CDW Corporation (NASDAQ: CDW)
XLAB vs CDW Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, CDW has a market cap of 19.7B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while CDW trades at $153.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas CDW's P/E ratio is 14.70. In terms of profitability, XLAB's ROE is N/A, compared to CDW's ROE of +0.43%. Regarding short-term risk, XLAB is more volatile compared to CDW. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CDW's competition here
Wipro Limited (NYSE: WIT)
XLAB vs WIT Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, WIT has a market cap of 17.8B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while WIT trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas WIT's P/E ratio is 13.29. In terms of profitability, XLAB's ROE is N/A, compared to WIT's ROE of +0.15%. Regarding short-term risk, XLAB is more volatile compared to WIT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check WIT's competition here
Leidos Holdings, Inc. (NYSE: LDOS)
XLAB vs LDOS Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, LDOS has a market cap of 16.7B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while LDOS trades at $133.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas LDOS's P/E ratio is 10.85. In terms of profitability, XLAB's ROE is N/A, compared to LDOS's ROE of +0.28%. Regarding short-term risk, XLAB is more volatile compared to LDOS. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check LDOS's competition here
CGI Inc. (NYSE: GIB)
XLAB vs GIB Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, GIB has a market cap of 16B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while GIB trades at $73.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas GIB's P/E ratio is 12.02. In terms of profitability, XLAB's ROE is N/A, compared to GIB's ROE of +0.17%. Regarding short-term risk, XLAB is more volatile compared to GIB. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check GIB's competition here
IREN Limited (NASDAQ: IREN)
XLAB vs IREN Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, IREN has a market cap of 14.9B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while IREN trades at $43.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas IREN's P/E ratio is -28.92. In terms of profitability, XLAB's ROE is N/A, compared to IREN's ROE of -0.23%. Regarding short-term risk, XLAB is more volatile compared to IREN. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check IREN's competition here
CACI International Inc (NYSE: CACI)
XLAB vs CACI Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, CACI has a market cap of 13.9B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while CACI trades at $621.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas CACI's P/E ratio is 21.13. In terms of profitability, XLAB's ROE is N/A, compared to CACI's ROE of +0.13%. Regarding short-term risk, XLAB is more volatile compared to CACI. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CACI's competition here
Wise Group plc Class A Ordinary Shares (NASDAQ: WSE)
XLAB vs WSE Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, WSE has a market cap of 13.2B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while WSE trades at $12.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas WSE's P/E ratio is 13.47. In terms of profitability, XLAB's ROE is N/A, compared to WSE's ROE of +0.26%. Regarding short-term risk, XLAB is more volatile compared to WSE. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check WSE's competition here
Gartner, Inc. (NYSE: IT)
XLAB vs IT Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, IT has a market cap of 13.1B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while IT trades at $187.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas IT's P/E ratio is 13.59. In terms of profitability, XLAB's ROE is N/A, compared to IT's ROE of +4.01%. Regarding short-term risk, XLAB is more volatile compared to IT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check IT's competition here
Jack Henry & Associates, Inc. (NASDAQ: JKHY)
XLAB vs JKHY Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, JKHY has a market cap of 12B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while JKHY trades at $165.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas JKHY's P/E ratio is 23.55. In terms of profitability, XLAB's ROE is N/A, compared to JKHY's ROE of +0.23%. Regarding short-term risk, XLAB is more volatile compared to JKHY. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check JKHY's competition here
Applied Digital Corp. (NASDAQ: APLD)
XLAB vs APLD Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, APLD has a market cap of 7.5B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while APLD trades at $26.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas APLD's P/E ratio is -37.01. In terms of profitability, XLAB's ROE is N/A, compared to APLD's ROE of -0.17%. Regarding short-term risk, XLAB is more volatile compared to APLD. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check APLD's competition here
Cipher Mining Inc. (NASDAQ: CIFR)
XLAB vs CIFR Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, CIFR has a market cap of 7.1B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while CIFR trades at $17.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas CIFR's P/E ratio is -6.07. In terms of profitability, XLAB's ROE is N/A, compared to CIFR's ROE of -1.56%. Regarding short-term risk, XLAB is more volatile compared to CIFR. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CIFR's competition here
Ingram Micro Holding Corporation (NYSE: INGM)
XLAB vs INGM Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, INGM has a market cap of 6.6B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while INGM trades at $28.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas INGM's P/E ratio is 9.39. In terms of profitability, XLAB's ROE is N/A, compared to INGM's ROE of +0.10%. Regarding short-term risk, XLAB is more volatile compared to INGM. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check INGM's competition here
Genpact Limited (NYSE: G)
XLAB vs G Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, G has a market cap of 6.4B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while G trades at $37.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas G's P/E ratio is 9.86. In terms of profitability, XLAB's ROE is N/A, compared to G's ROE of +0.23%. Regarding short-term risk, XLAB is more volatile compared to G. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check G's competition here
EPAM Systems, Inc. (NYSE: EPAM)
XLAB vs EPAM Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, EPAM has a market cap of 6.3B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while EPAM trades at $117.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas EPAM's P/E ratio is 9.53. In terms of profitability, XLAB's ROE is N/A, compared to EPAM's ROE of +0.11%. Regarding short-term risk, XLAB is more volatile compared to EPAM. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check EPAM's competition here
GDS Holdings Limited (NASDAQ: GDS)
XLAB vs GDS Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, GDS has a market cap of 6.1B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while GDS trades at $31.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas GDS's P/E ratio is 12.55. In terms of profitability, XLAB's ROE is N/A, compared to GDS's ROE of +0.13%. Regarding short-term risk, XLAB is more volatile compared to GDS. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check GDS's competition here
ExlService Holdings, Inc. (NASDAQ: EXLS)
XLAB vs EXLS Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, EXLS has a market cap of 5.7B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while EXLS trades at $36.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas EXLS's P/E ratio is 18.20. In terms of profitability, XLAB's ROE is N/A, compared to EXLS's ROE of +0.28%. Regarding short-term risk, XLAB is more volatile compared to EXLS. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check EXLS's competition here
Science Applications International Corporation (NASDAQ: SAIC)
XLAB vs SAIC Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, SAIC has a market cap of 5.3B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while SAIC trades at $125.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas SAIC's P/E ratio is 11.36. In terms of profitability, XLAB's ROE is N/A, compared to SAIC's ROE of +0.26%. Regarding short-term risk, XLAB is more volatile compared to SAIC. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check SAIC's competition here
Parsons Corporation (NYSE: PSN)
XLAB vs PSN Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, PSN has a market cap of 5B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while PSN trades at $46.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas PSN's P/E ratio is 19.81. In terms of profitability, XLAB's ROE is N/A, compared to PSN's ROE of +0.06%. Regarding short-term risk, XLAB is more volatile compared to PSN. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check PSN's competition here
Insight Enterprises, Inc. (NASDAQ: NSIT)
XLAB vs NSIT Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, NSIT has a market cap of 4.8B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while NSIT trades at $160.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas NSIT's P/E ratio is 13.12. In terms of profitability, XLAB's ROE is N/A, compared to NSIT's ROE of +0.13%. Regarding short-term risk, XLAB is more volatile compared to NSIT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check NSIT's competition here
NCR Corporation (NYSE: NCR)
XLAB vs NCR Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, NCR has a market cap of 3.8B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while NCR trades at $27.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas NCR's P/E ratio is 49.24. In terms of profitability, XLAB's ROE is N/A, compared to NCR's ROE of +0.17%. Regarding short-term risk, XLAB is more volatile compared to NCR. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check NCR's competition here
WNS (Holdings) Limited (NYSE: WNS)
XLAB vs WNS Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, WNS has a market cap of 3.3B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while WNS trades at $76.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas WNS's P/E ratio is 21.36. In terms of profitability, XLAB's ROE is N/A, compared to WNS's ROE of +0.09%. Regarding short-term risk, XLAB is more volatile compared to WNS. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check WNS's competition here
Kyndryl Holdings, Inc. (NYSE: KD)
XLAB vs KD Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, KD has a market cap of 2.9B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while KD trades at $13.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas KD's P/E ratio is 13.90. In terms of profitability, XLAB's ROE is N/A, compared to KD's ROE of +0.29%. Regarding short-term risk, XLAB is more volatile compared to KD. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check KD's competition here
Csquare Inc. (NYSE: CSQR)
XLAB vs CSQR Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, CSQR has a market cap of 2.8B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while CSQR trades at $18.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas CSQR's P/E ratio is N/A. In terms of profitability, XLAB's ROE is N/A, compared to CSQR's ROE of N/A. Regarding short-term risk, XLAB is more volatile compared to CSQR. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CSQR's competition here
Perficient, Inc. (NASDAQ: PRFT)
XLAB vs PRFT Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, PRFT has a market cap of 2.7B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while PRFT trades at $75.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas PRFT's P/E ratio is 36.34. In terms of profitability, XLAB's ROE is N/A, compared to PRFT's ROE of +0.21%. Regarding short-term risk, XLAB is more volatile compared to PRFT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check PRFT's competition here
Keel Infrastructure Corp. (NASDAQ: KEEL)
XLAB vs KEEL Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, KEEL has a market cap of 2B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while KEEL trades at $3.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas KEEL's P/E ratio is N/A. In terms of profitability, XLAB's ROE is N/A, compared to KEEL's ROE of -0.90%. Regarding short-term risk, XLAB is more volatile compared to KEEL. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check KEEL's competition here
Concentrix Corporation (NASDAQ: CNXC)
XLAB vs CNXC Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, CNXC has a market cap of 2B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while CNXC trades at $32.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas CNXC's P/E ratio is 2.99. In terms of profitability, XLAB's ROE is N/A, compared to CNXC's ROE of -0.42%. Regarding short-term risk, XLAB is more volatile compared to CNXC. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CNXC's competition here
Formula Systems (1985) Ltd. (NASDAQ: FORTY)
XLAB vs FORTY Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, FORTY has a market cap of 2B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while FORTY trades at $128.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas FORTY's P/E ratio is 30.30. In terms of profitability, XLAB's ROE is N/A, compared to FORTY's ROE of +0.54%. Regarding short-term risk, XLAB is more volatile compared to FORTY. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check FORTY's competition here
SharonAI Holdings, Inc. Class A Common Stock (NASDAQ: SHAZ)
XLAB vs SHAZ Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, SHAZ has a market cap of 1.9B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while SHAZ trades at $55.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas SHAZ's P/E ratio is -1.80. In terms of profitability, XLAB's ROE is N/A, compared to SHAZ's ROE of -1.57%. Regarding short-term risk, XLAB is more volatile compared to SHAZ. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check SHAZ's competition here
DXC Technology Company (NYSE: DXC)
XLAB vs DXC Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, DXC has a market cap of 1.9B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while DXC trades at $11.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas DXC's P/E ratio is 3.59. In terms of profitability, XLAB's ROE is N/A, compared to DXC's ROE of +0.04%. Regarding short-term risk, XLAB is more volatile compared to DXC. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check DXC's competition here
Innodata Inc. (NASDAQ: INOD)
XLAB vs INOD Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, INOD has a market cap of 1.8B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while INOD trades at $55.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas INOD's P/E ratio is 49.59. In terms of profitability, XLAB's ROE is N/A, compared to INOD's ROE of +0.38%. Regarding short-term risk, XLAB is more volatile compared to INOD. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check INOD's competition here
Globant S.A. (NYSE: GLOB)
XLAB vs GLOB Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, GLOB has a market cap of 1.7B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while GLOB trades at $39.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas GLOB's P/E ratio is 6.61. In terms of profitability, XLAB's ROE is N/A, compared to GLOB's ROE of +0.05%. Regarding short-term risk, XLAB is more volatile compared to GLOB. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check GLOB's competition here
VNET Group, Inc. (NASDAQ: VNET)
XLAB vs VNET Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, VNET has a market cap of 1.7B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while VNET trades at $6.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas VNET's P/E ratio is -5.16. In terms of profitability, XLAB's ROE is N/A, compared to VNET's ROE of -0.47%. Regarding short-term risk, XLAB is more volatile compared to VNET. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check VNET's competition here
Mega Fortune Company Limited (NASDAQ: MGRT)
XLAB vs MGRT Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, MGRT has a market cap of 1.5B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while MGRT trades at $116.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas MGRT's P/E ratio is 634.71. In terms of profitability, XLAB's ROE is N/A, compared to MGRT's ROE of +0.21%. Regarding short-term risk, XLAB is more volatile compared to MGRT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check MGRT's competition here
Thoughtworks Holding, Inc. (NASDAQ: TWKS)
XLAB vs TWKS Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, TWKS has a market cap of 1.4B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while TWKS trades at $4.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas TWKS's P/E ratio is -12.08. In terms of profitability, XLAB's ROE is N/A, compared to TWKS's ROE of -0.09%. Regarding short-term risk, XLAB is more volatile compared to TWKS. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check TWKS's competition here
BigBear.ai Holdings, Inc. (NYSE: BBAI)
XLAB vs BBAI Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, BBAI has a market cap of 1.4B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while BBAI trades at $2.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas BBAI's P/E ratio is -4.33. In terms of profitability, XLAB's ROE is N/A, compared to BBAI's ROE of -0.12%. Regarding short-term risk, XLAB is more volatile compared to BBAI. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check BBAI's competition here
Clarivate Plc (NYSE: CLVT)
XLAB vs CLVT Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, CLVT has a market cap of 1.4B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while CLVT trades at $2.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas CLVT's P/E ratio is 2.90. In terms of profitability, XLAB's ROE is N/A, compared to CLVT's ROE of -0.07%. Regarding short-term risk, XLAB is more volatile compared to CLVT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CLVT's competition here
Everforth, Inc. (NYSE: EFOR)
XLAB vs EFOR Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, EFOR has a market cap of 1.3B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while EFOR trades at $32.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas EFOR's P/E ratio is 7.37. In terms of profitability, XLAB's ROE is N/A, compared to EFOR's ROE of +0.05%. Regarding short-term risk, XLAB is more volatile compared to EFOR. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check EFOR's competition here
Bitfarms Ltd. (NASDAQ: BITF)
XLAB vs BITF Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, BITF has a market cap of 1.3B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while BITF trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas BITF's P/E ratio is -5.68. In terms of profitability, XLAB's ROE is N/A, compared to BITF's ROE of -0.90%. Regarding short-term risk, XLAB is more volatile compared to BITF. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check BITF's competition here
BIT Mining Limited (NYSE: BTCM)
XLAB vs BTCM Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, BTCM has a market cap of 1.3B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while BTCM trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas BTCM's P/E ratio is -0.53. In terms of profitability, XLAB's ROE is N/A, compared to BTCM's ROE of -0.32%. Regarding short-term risk, XLAB is more volatile compared to BTCM. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check BTCM's competition here
NCR Voyix Corporation (NYSE: VYX)
XLAB vs VYX Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, VYX has a market cap of 1.2B. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while VYX trades at $9.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas VYX's P/E ratio is 10.07. In terms of profitability, XLAB's ROE is N/A, compared to VYX's ROE of +0.07%. Regarding short-term risk, XLAB is more volatile compared to VYX. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check VYX's competition here
ASGN Incorporated (NYSE: ASGN)
XLAB vs ASGN Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, ASGN has a market cap of 895M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while ASGN trades at $20.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas ASGN's P/E ratio is 9.32. In terms of profitability, XLAB's ROE is N/A, compared to ASGN's ROE of +0.05%. Regarding short-term risk, XLAB is more volatile compared to ASGN. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check ASGN's competition here
SOLAI Limited (NYSE: SLAI)
XLAB vs SLAI Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, SLAI has a market cap of 880.1M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while SLAI trades at $3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas SLAI's P/E ratio is -1.40. In terms of profitability, XLAB's ROE is N/A, compared to SLAI's ROE of -0.83%. Regarding short-term risk, XLAB is less volatile compared to SLAI. This indicates lower risk in terms of short-term price fluctuations for XLAB.Check SLAI's competition here
Magic Software Enterprises Ltd. (NASDAQ: MGIC)
XLAB vs MGIC Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, MGIC has a market cap of 853.3M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while MGIC trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas MGIC's P/E ratio is 21.20. In terms of profitability, XLAB's ROE is N/A, compared to MGIC's ROE of +0.11%. Regarding short-term risk, XLAB is more volatile compared to MGIC. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check MGIC's competition here
HIVE Digital Technologies Ltd. (NASDAQ: HIVE)
XLAB vs HIVE Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, HIVE has a market cap of 834.6M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while HIVE trades at $3.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas HIVE's P/E ratio is -2.50. In terms of profitability, XLAB's ROE is N/A, compared to HIVE's ROE of -0.60%. Regarding short-term risk, XLAB is more volatile compared to HIVE. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check HIVE's competition here
Cantaloupe, Inc. (NASDAQ: CTLP)
XLAB vs CTLP Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, CTLP has a market cap of 825.8M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while CTLP trades at $11.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas CTLP's P/E ratio is 280.00. In terms of profitability, XLAB's ROE is N/A, compared to CTLP's ROE of +0.01%. Regarding short-term risk, XLAB is more volatile compared to CTLP. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CTLP's competition here
Clarivate Plc (NYSE: CLVT-PA)
XLAB vs CLVT-PA Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, CLVT-PA has a market cap of 755.5M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while CLVT-PA trades at $4.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas CLVT-PA's P/E ratio is -7.93. In terms of profitability, XLAB's ROE is N/A, compared to CLVT-PA's ROE of -0.07%. Regarding short-term risk, XLAB is more volatile compared to CLVT-PA. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CLVT-PA's competition here
N-able, Inc. (NYSE: NABL)
XLAB vs NABL Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, NABL has a market cap of 750.7M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while NABL trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas NABL's P/E ratio is 10.22. In terms of profitability, XLAB's ROE is N/A, compared to NABL's ROE of -0.01%. Regarding short-term risk, XLAB is more volatile compared to NABL. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check NABL's competition here
TaskUs, Inc. (NASDAQ: TASK)
XLAB vs TASK Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, TASK has a market cap of 728.9M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while TASK trades at $7.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas TASK's P/E ratio is 5.39. In terms of profitability, XLAB's ROE is N/A, compared to TASK's ROE of +0.25%. Regarding short-term risk, XLAB is more volatile compared to TASK. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check TASK's competition here
WhiteFiber, Inc. Ordinary Shares (NASDAQ: WYFI)
XLAB vs WYFI Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, WYFI has a market cap of 725.2M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while WYFI trades at $19.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas WYFI's P/E ratio is -11.16. In terms of profitability, XLAB's ROE is N/A, compared to WYFI's ROE of -0.09%. Regarding short-term risk, XLAB is more volatile compared to WYFI. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check WYFI's competition here
Grid Dynamics Holdings, Inc. (NASDAQ: GDYN)
XLAB vs GDYN Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, GDYN has a market cap of 665.2M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while GDYN trades at $8.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas GDYN's P/E ratio is 21.58. In terms of profitability, XLAB's ROE is N/A, compared to GDYN's ROE of +0.01%. Regarding short-term risk, XLAB is more volatile compared to GDYN. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check GDYN's competition here
Verra Mobility Corporation (NASDAQ: VRRM)
XLAB vs VRRM Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, VRRM has a market cap of 638M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while VRRM trades at $4.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas VRRM's P/E ratio is 3.23. In terms of profitability, XLAB's ROE is N/A, compared to VRRM's ROE of +0.15%. Regarding short-term risk, XLAB is more volatile compared to VRRM. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check VRRM's competition here
Performant Healthcare, Inc. (NASDAQ: PHLT)
XLAB vs PHLT Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, PHLT has a market cap of 611.6M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while PHLT trades at $7.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas PHLT's P/E ratio is -775.00. In terms of profitability, XLAB's ROE is N/A, compared to PHLT's ROE of +0.02%. Regarding short-term risk, XLAB is more volatile compared to PHLT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check PHLT's competition here
BigBear.ai Holdings, Inc. WT (NYSE: BBAI-WT)
XLAB vs BBAI-WT Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, BBAI-WT has a market cap of 576.6M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while BBAI-WT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas BBAI-WT's P/E ratio is -0.07. In terms of profitability, XLAB's ROE is N/A, compared to BBAI-WT's ROE of -0.12%. Regarding short-term risk, XLAB is less volatile compared to BBAI-WT. This indicates lower risk in terms of short-term price fluctuations for XLAB.Check BBAI-WT's competition here
IBEX Limited (NASDAQ: IBEX)
XLAB vs IBEX Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, IBEX has a market cap of 527.7M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while IBEX trades at $38.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas IBEX's P/E ratio is 11.10. In terms of profitability, XLAB's ROE is N/A, compared to IBEX's ROE of +0.32%. Regarding short-term risk, XLAB is more volatile compared to IBEX. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check IBEX's competition here
Alight, Inc. (NYSE: ALIT)
XLAB vs ALIT Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, ALIT has a market cap of 392M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while ALIT trades at $14.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas ALIT's P/E ratio is 6.17. In terms of profitability, XLAB's ROE is N/A, compared to ALIT's ROE of -1.59%. Regarding short-term risk, XLAB is more volatile compared to ALIT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check ALIT's competition here
Telos Corporation (NASDAQ: TLS)
XLAB vs TLS Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, TLS has a market cap of 364.4M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while TLS trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas TLS's P/E ratio is 27.06. In terms of profitability, XLAB's ROE is N/A, compared to TLS's ROE of -0.16%. Regarding short-term risk, XLAB is more volatile compared to TLS. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check TLS's competition here
Conduent Incorporated (NASDAQ: CNDT)
XLAB vs CNDT Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, CNDT has a market cap of 293.1M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while CNDT trades at $1.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas CNDT's P/E ratio is -4.97. In terms of profitability, XLAB's ROE is N/A, compared to CNDT's ROE of -0.30%. Regarding short-term risk, XLAB is more volatile compared to CNDT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CNDT's competition here
The Hackett Group, Inc. (NASDAQ: HCKT)
XLAB vs HCKT Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, HCKT has a market cap of 279.1M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while HCKT trades at $11.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas HCKT's P/E ratio is 7.64. In terms of profitability, XLAB's ROE is N/A, compared to HCKT's ROE of +0.22%. Regarding short-term risk, XLAB is more volatile compared to HCKT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check HCKT's competition here
Webull Corporation Incentive Warrant (NASDAQ: BULLZ)
XLAB vs BULLZ Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, BULLZ has a market cap of 260.4M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while BULLZ trades at $1.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas BULLZ's P/E ratio is N/A. In terms of profitability, XLAB's ROE is N/A, compared to BULLZ's ROE of +0.04%. Regarding short-term risk, XLAB is less volatile compared to BULLZ. This indicates lower risk in terms of short-term price fluctuations for XLAB.Check BULLZ's competition here
TSS, Inc. (NASDAQ: TSSI)
XLAB vs TSSI Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, TSSI has a market cap of 227.4M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while TSSI trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas TSSI's P/E ratio is 16.53. In terms of profitability, XLAB's ROE is N/A, compared to TSSI's ROE of +0.19%. Regarding short-term risk, XLAB is more volatile compared to TSSI. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check TSSI's competition here
Unisys Corporation (NYSE: UIS)
XLAB vs UIS Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, UIS has a market cap of 189.2M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while UIS trades at $2.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas UIS's P/E ratio is 3.13. In terms of profitability, XLAB's ROE is N/A, compared to UIS's ROE of +1.35%. Regarding short-term risk, XLAB is more volatile compared to UIS. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check UIS's competition here
Startek, Inc. (NYSE: SRT)
XLAB vs SRT Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, SRT has a market cap of 178.3M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while SRT trades at $4.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas SRT's P/E ratio is -6.60. In terms of profitability, XLAB's ROE is N/A, compared to SRT's ROE of -0.00%. Regarding short-term risk, XLAB is more volatile compared to SRT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check SRT's competition here
Robot Consulting Co., Ltd. ADS (NASDAQ: LAWR)
XLAB vs LAWR Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, LAWR has a market cap of 172.4M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while LAWR trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas LAWR's P/E ratio is -53.57. In terms of profitability, XLAB's ROE is N/A, compared to LAWR's ROE of +1.39%. Regarding short-term risk, XLAB is more volatile compared to LAWR. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check LAWR's competition here
Computer Task Group, Incorporated (NASDAQ: CTG)
XLAB vs CTG Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, CTG has a market cap of 169M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while CTG trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas CTG's P/E ratio is 350.00. In terms of profitability, XLAB's ROE is N/A, compared to CTG's ROE of +0.07%. Regarding short-term risk, XLAB is more volatile compared to CTG. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CTG's competition here
Endava plc (NYSE: DAVA)
XLAB vs DAVA Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, DAVA has a market cap of 165.8M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while DAVA trades at $3.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas DAVA's P/E ratio is 3.87. In terms of profitability, XLAB's ROE is N/A, compared to DAVA's ROE of -0.88%. Regarding short-term risk, XLAB is more volatile compared to DAVA. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check DAVA's competition here
KORE Group Holdings, Inc. (NYSE: KORE)
XLAB vs KORE Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, KORE has a market cap of 163M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while KORE trades at $9.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas KORE's P/E ratio is -4.97. In terms of profitability, XLAB's ROE is N/A, compared to KORE's ROE of +0.48%. Regarding short-term risk, XLAB is more volatile compared to KORE. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check KORE's competition here
Alithya Group Inc. (NASDAQ: ALYA)
XLAB vs ALYA Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, ALYA has a market cap of 110.3M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while ALYA trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas ALYA's P/E ratio is -3.42. In terms of profitability, XLAB's ROE is N/A, compared to ALYA's ROE of -0.09%. Regarding short-term risk, XLAB is more volatile compared to ALYA. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check ALYA's competition here
WidePoint Corporation (AMEX: WYY)
XLAB vs WYY Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, WYY has a market cap of 109.5M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while WYY trades at $11.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas WYY's P/E ratio is -85.15. In terms of profitability, XLAB's ROE is N/A, compared to WYY's ROE of -0.11%. Regarding short-term risk, XLAB is more volatile compared to WYY. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check WYY's competition here
ZenaTech, Inc. (NASDAQ: ZENA)
XLAB vs ZENA Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, ZENA has a market cap of 105.1M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while ZENA trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas ZENA's P/E ratio is -1.05. In terms of profitability, XLAB's ROE is N/A, compared to ZENA's ROE of -1.21%. Regarding short-term risk, XLAB is more volatile compared to ZENA. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check ZENA's competition here
Yuanbao Inc. American Depositary Shares (NASDAQ: YB)
XLAB vs YB Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, YB has a market cap of 103.8M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while YB trades at $13.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas YB's P/E ratio is 3.12. In terms of profitability, XLAB's ROE is N/A, compared to YB's ROE of +0.44%. Regarding short-term risk, XLAB is more volatile compared to YB. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check YB's competition here
CSP Inc. (NASDAQ: CSPI)
XLAB vs CSPI Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, CSPI has a market cap of 81.4M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while CSPI trades at $8.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas CSPI's P/E ratio is -115.43. In terms of profitability, XLAB's ROE is N/A, compared to CSPI's ROE of -0.02%. Regarding short-term risk, XLAB is more volatile compared to CSPI. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CSPI's competition here
ChronoScale Corporation (NASDAQ: CHRN)
XLAB vs CHRN Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, CHRN has a market cap of 71.6M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while CHRN trades at $19.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas CHRN's P/E ratio is -3.54. In terms of profitability, XLAB's ROE is N/A, compared to CHRN's ROE of N/A. Regarding short-term risk, XLAB is more volatile compared to CHRN. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CHRN's competition here
TTEC Holdings, Inc. (NASDAQ: TTEC)
XLAB vs TTEC Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, TTEC has a market cap of 67.1M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while TTEC trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas TTEC's P/E ratio is 1.44. In terms of profitability, XLAB's ROE is N/A, compared to TTEC's ROE of -1.62%. Regarding short-term risk, XLAB is more volatile compared to TTEC. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check TTEC's competition here
Quantum X Labs Inc. (NASDAQ: QXL)
XLAB vs QXL Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, QXL has a market cap of 61.3M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while QXL trades at $4.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas QXL's P/E ratio is -92.00. In terms of profitability, XLAB's ROE is N/A, compared to QXL's ROE of -0.14%. Regarding short-term risk, XLAB is more volatile compared to QXL. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check QXL's competition here
Castellum, Inc. (AMEX: CTM)
XLAB vs CTM Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, CTM has a market cap of 57.1M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while CTM trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas CTM's P/E ratio is -46.10. In terms of profitability, XLAB's ROE is N/A, compared to CTM's ROE of -0.06%. Regarding short-term risk, XLAB is more volatile compared to CTM. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CTM's competition here
SAIHEAT Limited (NASDAQ: SAIH)
XLAB vs SAIH Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, SAIH has a market cap of 45.9M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while SAIH trades at $25.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas SAIH's P/E ratio is -4.56. In terms of profitability, XLAB's ROE is N/A, compared to SAIH's ROE of -0.68%. Regarding short-term risk, XLAB is more volatile compared to SAIH. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check SAIH's competition here
Sify Technologies Limited Rights expiring 6/21/2024 (NASDAQ: SIFYR)
XLAB vs SIFYR Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, SIFYR has a market cap of 44.3M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while SIFYR trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas SIFYR's P/E ratio is N/A. In terms of profitability, XLAB's ROE is N/A, compared to SIFYR's ROE of N/A. Regarding short-term risk, XLAB is less volatile compared to SIFYR. This indicates lower risk in terms of short-term price fluctuations for XLAB.Check SIFYR's competition here
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO)
XLAB vs EKSO Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, EKSO has a market cap of 38.6M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while EKSO trades at $15.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas EKSO's P/E ratio is -3.11. In terms of profitability, XLAB's ROE is N/A, compared to EKSO's ROE of -1.77%. Regarding short-term risk, XLAB is more volatile compared to EKSO. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check EKSO's competition here
CLPS Incorporation (NASDAQ: CLPS)
XLAB vs CLPS Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, CLPS has a market cap of 31.6M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while CLPS trades at $1.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas CLPS's P/E ratio is -4.47. In terms of profitability, XLAB's ROE is N/A, compared to CLPS's ROE of -0.12%. Regarding short-term risk, XLAB is more volatile compared to CLPS. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CLPS's competition here
9F Inc. (NASDAQ: JFU)
XLAB vs JFU Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, JFU has a market cap of 29.7M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while JFU trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas JFU's P/E ratio is 540.77. In terms of profitability, XLAB's ROE is N/A, compared to JFU's ROE of +0.04%. Regarding short-term risk, XLAB is more volatile compared to JFU. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check JFU's competition here
ChowChow Cloud International Holdings Ltd. (AMEX: CHOW)
XLAB vs CHOW Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, CHOW has a market cap of 16.8M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while CHOW trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas CHOW's P/E ratio is -5.25. In terms of profitability, XLAB's ROE is N/A, compared to CHOW's ROE of -0.58%. Regarding short-term risk, XLAB is more volatile compared to CHOW. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CHOW's competition here
Global Engine Group Holding Limited Ordinary Shares (NASDAQ: GLE)
XLAB vs GLE Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, GLE has a market cap of 11.7M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while GLE trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas GLE's P/E ratio is -7.29. In terms of profitability, XLAB's ROE is N/A, compared to GLE's ROE of +0.20%. Regarding short-term risk, XLAB is more volatile compared to GLE. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check GLE's competition here
Sigma Labs, Inc. (NASDAQ: SGLB)
XLAB vs SGLB Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, SGLB has a market cap of 11.3M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while SGLB trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas SGLB's P/E ratio is -1.37. In terms of profitability, XLAB's ROE is N/A, compared to SGLB's ROE of -2.65%. Regarding short-term risk, XLAB is more volatile compared to SGLB. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check SGLB's competition here
Alarum Technologies Ltd. (NASDAQ: ALAR)
XLAB vs ALAR Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, ALAR has a market cap of 9.7M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while ALAR trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas ALAR's P/E ratio is 2.16. In terms of profitability, XLAB's ROE is N/A, compared to ALAR's ROE of +0.04%. Regarding short-term risk, XLAB is more volatile compared to ALAR. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check ALAR's competition here
LZ Technology Holdings Limited Class B Ordinary Shares (NASDAQ: LZMH)
XLAB vs LZMH Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, LZMH has a market cap of 9.7M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while LZMH trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas LZMH's P/E ratio is -0.37. In terms of profitability, XLAB's ROE is N/A, compared to LZMH's ROE of -3.05%. Regarding short-term risk, XLAB is more volatile compared to LZMH. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check LZMH's competition here
ARB IOT Group Limited (NASDAQ: ARBB)
XLAB vs ARBB Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, ARBB has a market cap of 7.5M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while ARBB trades at $4.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas ARBB's P/E ratio is -0.56. In terms of profitability, XLAB's ROE is N/A, compared to ARBB's ROE of -0.07%. Regarding short-term risk, XLAB is more volatile compared to ARBB. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check ARBB's competition here
Trident Digital Tech Holdings Ltd (NASDAQ: TDTH)
XLAB vs TDTH Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, TDTH has a market cap of 7.1M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while TDTH trades at $1.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas TDTH's P/E ratio is -0.26. In terms of profitability, XLAB's ROE is N/A, compared to TDTH's ROE of +3.18%. Regarding short-term risk, XLAB is more volatile compared to TDTH. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check TDTH's competition here
Data Storage Corporation (NASDAQ: DTST)
XLAB vs DTST Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, DTST has a market cap of 6.5M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while DTST trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas DTST's P/E ratio is 43.00. In terms of profitability, XLAB's ROE is N/A, compared to DTST's ROE of +0.71%. Regarding short-term risk, XLAB is more volatile compared to DTST. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check DTST's competition here
Cycurion, Inc. Common Stock (NASDAQ: CYCU)
XLAB vs CYCU Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, CYCU has a market cap of 4.8M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while CYCU trades at $3.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas CYCU's P/E ratio is -0.41. In terms of profitability, XLAB's ROE is N/A, compared to CYCU's ROE of -0.71%. Regarding short-term risk, XLAB is more volatile compared to CYCU. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CYCU's competition here
Veea Inc. (NASDAQ: VEEA)
XLAB vs VEEA Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, VEEA has a market cap of 4.7M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while VEEA trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas VEEA's P/E ratio is -21.50. In terms of profitability, XLAB's ROE is N/A, compared to VEEA's ROE of +51.66%. Regarding short-term risk, XLAB is more volatile compared to VEEA. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check VEEA's competition here
CID HoldCo, Inc. (NASDAQ: DAIC)
XLAB vs DAIC Comparison September 2026
Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLAB stands at 100.6M. In comparison, DAIC has a market cap of 4M. Regarding current trading prices, XLAB is priced at $4.66 on the NASDAQ, while DAIC trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLAB currently has a P/E ratio of 23.15, whereas DAIC's P/E ratio is -0.07. In terms of profitability, XLAB's ROE is N/A, compared to DAIC's ROE of +37.71%. Regarding short-term risk, XLAB is more volatile compared to DAIC. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check DAIC's competition here